![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Directeur Technique/Scientifique/R&D chez
KYMERA THERAPEUTICS, INC.
Fortune : 6 M $ au 31/05/2026
Profil
Jared Gollob is Chief Medical Officer at Kymera Therapeutics, Inc. since 2018.
Formerly, Dr. Gollob was Director of the Biologic Therapy Program at Duke University from 2002 to 2007.
From 2012 to 2018, Dr. Gollob was Global VP of Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 71 359 ( 0,09 % ) | 6 M $ | 31/05/2026 |
Postes actifs de Jared Gollob
| Sociétés | Poste | Début |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2018 |
Anciens postes connus de Jared Gollob
| Sociétés | Poste | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2007 |
Formation de Jared Gollob
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
